Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of Inflammation and Platelet Activation in Adverse Cardiovascular Outcomes of Critical Limb Ischaemia Patients – Double-blind Randomised Trial of Clopidogrel
2005-000960-25Phase 4Completed
- Sponsor
- NHS Lothian
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of clopidogrel in peripheral artery occlusion (PAD) (2 arms), sponsored by NHS Lothian. Primary endpoint: Platelet-monocyte binding levels. Started Apr 2005; status: completed.
02
Drugs
clopidogrel
03
Conditions
peripheral artery occlusion (PAD)
Beyond the preview
Go deeper on 2005-000960-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000960-25.